Rule 8.1 - Alltracel Pharm

RNS Number:2988R
J & E Davy
01 April 2008


                                                                        FORM 8.1

                              IRISH TAKEOVER PANEL


 Lodge with the Irish Stock Exchange (Company Announcements Office) (which will
                                 publicise) and
the Panel. Use separate form for each class of securities in which dealings have
                                   been made.

                                Date of Disclosure:   01st April 2008


DISCLOSURE UNDER RULE 8.1(a), 8.1(b)(I) and 8.3 OF THE IRISH TAKEOVER PANEL ACT
                          1997, (TAKEOVER) RULES, 1997

Date of Dealing:                  31st March 2008


Dealing in                        Alltracel Pharmaceuticals



(1)    Class of Securities (e.g. ordinary shares)     Ordinary Eur 0.125


(2)


Amount bought                       Amount sold                        Price per unit

-                                   80,000                             GBP 0.1275



(3)           Resultant total of the same class owned or controlled (and
percentage of class)                      484,532                 (0.339%)


(4)           Party making disclosure     J&E Davy

(5)           EITHER (a)          Name of purchaser/vendor    J&E Davy

       OR            (b)          If dealing for discretionary client(s),
                                  name of fund management Organisation


(6)           Reason for disclosure

                 (a)          (I)     offeror or associate of offeror     NO

                             (II)     offeree or associate of offeree    YES


    Specify which category or categories of associate ((a) to (l) page 3/4)

                If category (l) explain


                 (b)          Rule 8.3 (i.e. disclosure because of ownership or
control of 1% or more of the class of relevant securities dealt in)      NO



Signed, for and on behalf of the party named in (4) above
___________________________

(Also print name of signatory)                 Mark Smyth

Telephone and extension number                 01-6149063


This announcement has been issued through the Companies Announcement Service of
                           The Irish Stock Exchange.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

DCCBBGDSDSGGGIB

Alltracel Pharmaceuticals (LSE:AP.)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024